首页> 外文期刊>Reproductive Health >Clinical review of 24–35?year olds conceived with and without in vitro fertilization: study protocol
【24h】

Clinical review of 24–35?year olds conceived with and without in vitro fertilization: study protocol

机译:接受和不接受体外受精的24-35岁人群的临床评价:研究方案

获取原文
           

摘要

Background Children conceived by assisted reproductive technologies (ART) currently comprise 4% of Australian births. The manipulation of biological parameters related to fertilization and implantation are integral to successful ART but potentially pose a risk to the longer-term health of the offspring. There is consensus that many common adult health problems (particularly cardiovascular, metabolic and respiratory conditions) have their origins in early life, possibly before birth, and that risk trajectories track through childhood until clinical disease manifests in adulthood. Early life epigenetic variation may play a role in this process. However little is known about the long-term health of individuals conceived by ART. In a previous study, based on telephone-interviews, we found that young adults conceived by in vitro fertilization (IVF) had significantly more maternal reported atopic respiratory, endocrine, nutritional, and metabolic conditions than non-IVF conceived matched controls. Here we outline the protocol for a follow-up biomedical assessment of this cohort and a questionnaire to obtain information on potential confounders. Methods We are conducting a clinical review of an existing, well characterised cohort comprising 547 IVF-conceived adults and 549 matched controls. We are measuring cardiovascular intermediate phenotypes, metabolic parameters and respiratory function, complemented by epigenome-wide DNA methylation analysis. A pilot study demonstrated the feasibility of our proposed protocol and its acceptability to participants. Participants attend a 2–3?h clinical assessment and complete a study-specific online questionnaire. Measurements include: 1) cardiovascular phenotypes: carotid artery intima-media thickness and distensibility, retinal vascular calibre, resting blood pressure, pulse wave velocity and pulse wave analysis; 2) respiratory function: spirometry, plethysmography, multiple breath washout; 3) auxology: height, weight, waist circumference, bio-impedance. Blood is collected for 4) biomarkers of cardiometabolic profile including inflammatory markers and 5) epigenetic analysis. Discussion Recruitment for this clinical review is challenging as many of the participants have moved to regional, interstate or international locations. Additionally, many female participants are pregnant or breastfeeding, and are therefore ineligible. Nevertheless, comprehensive strategies have been developed to optimize recruitment. Given the increasing use of IVF and related technologies, the potential long-term consequences for risk of common adult diseases is an important clinical and public health issue.
机译:背景技术辅助生殖技术(ART)孕育的儿童目前占澳大利亚出生人口的4%。与受精和植入有关的生物学参数的操纵是成功抗逆转录病毒疗法必不可少的,但可能对后代的长期健康构成威胁。人们已经达成共识,许多常见的成人健康问题(尤其是心血管,代谢和呼吸系统疾病)起源于生命的早期,可能是在出生之前,并且风险轨迹一直贯穿儿童期,直到临床疾病在成年期表现出来。早期生命的表观遗传变异可能在此过程中起作用。然而,对于ART所构想的个体的长期健康知之甚少。在先前的研究中,基于电话访谈,我们发现通过体外受精(IVF)怀孕的年轻人比非IVF怀孕的配对对照具有更高的母亲报告的异位呼吸,内分泌,营养和代谢状况。在这里,我们概述了该人群的后续生物医学评估方案和一份问卷,以获取有关潜在混杂因素的信息。方法我们正在对一个现有的,特征明确的队列进行临床检查,该队列包括547个试管婴儿受孕的成年人和549个匹配的对照。我们正在测量心血管中间表型,代谢参数和呼吸功能,并辅以表观基因组范围的DNA甲基化分析。一项初步研究证明了我们提出的协议的可行性及其对参与者的可接受性。参加者参加2-3小时的临床评估,并完成一项针对研究的在线问卷。测量包括:1)心血管表型:颈动脉内膜中层厚度和扩张性,视网膜血管口径,静息血压,脉搏波速度和脉搏波分析; 2)呼吸功能:肺活量测定法,体积描记法,多次呼吸冲洗; 3)生理学:身高,体重,腰围,生物阻抗。收集血液用于4)心脏代谢特征的生物标志物,包括炎症标志物和5)表观遗传分析。讨论由于许多参与者已转移到区域,州际或国际地点,因此招募该临床评价具有挑战性。另外,许多女性参与者怀孕或哺乳,因此不符合资格。尽管如此,已经开发了综合策略来优化招聘。鉴于体外受精和相关技术的使用越来越多,对常见成人疾病风险的潜在长期后果是重要的临床和公共卫生问题。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号